← Eichor
Condition: Donor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Donor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Phlebotomy on Heartrate in Polycythemia Patients
Phase N/A · 1 location(s) · Leiden University Medical Center · NCT05396170A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Ce
Phase 1 · 21 location(s) · TScan Therapeutics, Inc. · NCT05473910A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditionin
Phase 2 · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT06557161NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Phase 2 · 13 location(s) · New Approaches to Neuroblastoma Therapy Consortium · NCT06450041MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NA · 1 location(s) · Medical College of Wisconsin · NCT05794880CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure
NA · 1 location(s) · NYU Langone Health · NCT06569082Methods of T Cell Depletion Trial (MoTD)
Phase 2 · 17 location(s) · University of Birmingham · NCT04888741Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT07347769Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07301853REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT05628974Anxiety Levels in Living Liver Donors
Phase N/A · 1 location(s) · Inonu University · NCT07576920TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantat
Phase 1 · 2 location(s) · Stanford University · NCT03943238Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the Ex
NA · 4 location(s) · Institut Claudius Regaud · NCT05757817Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Phase 2 · 9 location(s) · New York Medical College · NCT03266640Targeted Fortification of Donor Breast Milk in Preterm Infants
NA · 1 location(s) · Columbia University · NCT04294368TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic D
Phase 2 · 1 location(s) · Johns Hopkins All Children's Hospital · NCT04414046Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation.
NA · 1 location(s) · Hospices Civils de Lyon · NCT06047106Risk Factors and Outcome of Biliary Complications Following Adult Living Donor Liver Transplantation
Phase N/A · 2 location(s) · Assiut University · NCT03789383Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL
Phase 1 · 1 location(s) · Liping Dou · NCT07677878Pinoxin for the Prevention of Radiation-Induced Skin Injury
Phase 2 · 2 location(s) · Fudan University · NCT07545720Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Phase 1/Phase 2 · 7 location(s) · New York Medical College · NCT04197596Analysis of the Reliability and Validity of Laser Speckle Contrast Imaging
NA · 1 location(s) · Universidad Complutense de Madrid · NCT07527351Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation
NA · 1 location(s) · Istanbul Medipol University Hospital · NCT07304466CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Phase 3 · 1 location(s) · Peking University People's Hospital · NCT07441291Radial Forearm Donor Site Closure
NA · 1 location(s) · University of British Columbia · NCT05740033Third Party Viral Specific T-cells (VSTs)
Phase 2 · 4 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02532452Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Phase 1 · 1 location(s) · Stanford University · NCT06551584A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
Phase N/A · 1 location(s) · BioCytics, Inc. · NCT00571389Comparison of the Postoperative Analgesic Effects of ITM and Bi-level ESPB in Liver Transplantation Donors
NA · 1 location(s) · Ankara Etlik City Hospital · NCT07123740
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.